
The National Pharmaceutical Pricing Authority (NPPA) on March 06, 2025, issued the Computation of Retail Price of Olmesartan Medoxomil IP 40 mg + Amlodipine Besilate IP Eq. to Amlodipine 5 mg + Hydrochlorothiazide IP 12.5 mg for M/s Windlas Biotech Limited (Manufacturer) & M/s Alkem Wellness Limited (Marketer).
The following has been stated namely: -
• The Retail Price has been computed based on the data from July 2025
• The Retail Price has been computed for Each Film Coated Tablet Containing Olmesartan Medoxomil IP 40 mg + Amlodipine Besilate IP Eq. to Amlodipine 5 mg + Hydrochlorothiazide IP 12.5 mg for M/s Windlas Biotech Limited (Manufacturer) & M/s Alkem Wellness Limited (Marketer).
• The Total MAT is 81,84,49,134
[Notification No. 19(5012)/2026/DP/NPPA/Div.II]